Steroid intraocular implants having an extended sustained release for a period of greater than two months

Details for Australian Patent Application No. 2005240092 (hide)

Owner Allergan, Inc.

Inventors Chang, James N.; Blanda, Wendy M.; Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Olejnik, Orest; Sugimoto, Hiroshi

Agent Davies Collison Cave

Pub. Number AU-B-2005240092

PCT Pub. Number WO2005/107727

Priority 10/837,356 30.04.04 US

Filing date 28 April 2005

Wipo publication date 17 November 2005

Acceptance publication date 1 April 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/573 (2006.01)

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107727 Priority application(s): WO2005/107727

1 April 2010 Application Accepted

  Published as AU-B-2005240092

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240093-Biodegradable intravitreal tyrosine kinase inhibitors implants

2005240091-Hybrid recombinases for genome manipulation